Ocular Therapeutix grants equity awards to 15 new employees
The awards cover options on up to 70,150 shares and restricted stock units representing 22,900 shares, with grants effective Oct. 5.
Key takeaways
- Ocular granted inducement equity awards to 15 newly hired non-executive employees.
- The awards include options on up to 70,150 shares and restricted stock units for 22,900 shares.
Ocular Therapeutix granted inducement equity awards to 15 newly hired non-executive employees, effective Oct. 5. The awards include stock options to purchase up to 70,150 shares and restricted stock units representing 22,900 shares.
The options have an exercise price of $7.25 per share, equal to Ocular’s closing share price on the grant date. They have a ten-year term and vest over four years, subject to continued service.
The restricted stock units vest in equal annual installments over three years, also subject to continued service. Ocular said the awards were made under its 2019 Inducement Stock Incentive Plan in accordance with Nasdaq Listing Rule 5635(c)(4).
This article was produced with the help of AI technology. Source: Yahoo Finance
